🚀 VC round data is live in beta, check it out!
Euroinvestment Valuation Multiples
Discover revenue and EBITDA valuation multiples for Euroinvestment and similar public comparables like Co-Diagnostics, Fonet, Novacyt, Anatolia Geneworks and more.
Euroinvestment Overview
About Euroinvestment
Euroinvestment SA is a holding company. It is engaged in providing dental and prosthetic laboratory services. It serves through a network of 6 clinics in Warsaw, Poland.
Founded
2007
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$3M
Euroinvestment Financials
Euroinvestment reported last fiscal year revenue of — and EBITDA of $29K.
In the same fiscal year, Euroinvestment generated — in gross profit, $29K in EBITDA, and had net loss of ($40K).
Euroinvestment P&L
In the most recent fiscal year, Euroinvestment reported revenue of — and EBITDA of $29K.
Euroinvestment expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | $29K | XXX | XXX | XXX |
| Net Profit | — | XXX | ($40K) | XXX | XXX | XXX |
| Net Debt | — | — | $499K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Euroinvestment Stock Performance
Euroinvestment has current market cap of $2M, and enterprise value of $3M.
Market Cap Evolution
Euroinvestment's stock price is $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3M | $2M | — | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEuroinvestment Valuation Multiples
Euroinvestment trades at 97.7x EV/EBITDA.
Euroinvestment Financial Valuation Multiples
As of March 29, 2026, Euroinvestment has market cap of $2M and EV of $3M.
Equity research analysts estimate Euroinvestment's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Euroinvestment has a P/E ratio of (58.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $3M | XXX | $3M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 97.7x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 97.7x | XXX | XXX | XXX |
| P/E | — | XXX | (58.9x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (7.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Euroinvestment Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Euroinvestment Public Comps
See public comps and valuation multiples for other Laboratory Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Co-Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Fonet | XXX | XXX | XXX | XXX | XXX | XXX |
| Novacyt | XXX | XXX | XXX | XXX | XXX | XXX |
| Anatolia Geneworks | XXX | XXX | XXX | XXX | XXX | XXX |
| BATM Advanced Communications | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Euroinvestment M&A Activity
Euroinvestment acquired XXX companies to date.
Last acquisition by Euroinvestment was on XXXXXXXX, XXXXX. Euroinvestment acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Euroinvestment
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEuroinvestment Investment Activity
Euroinvestment invested in XXX companies to date.
Euroinvestment made its latest investment on XXXXXXXX, XXXXX. Euroinvestment invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Euroinvestment
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Euroinvestment
| When was Euroinvestment founded? | Euroinvestment was founded in 2007. |
| Where is Euroinvestment headquartered? | Euroinvestment is headquartered in Poland. |
| Is Euroinvestment publicly listed? | Yes, Euroinvestment is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Euroinvestment? | Euroinvestment trades under VIV ticker. |
| When did Euroinvestment go public? | Euroinvestment went public in 2007. |
| Who are competitors of Euroinvestment? | Euroinvestment main competitors are Co-Diagnostics, Fonet, Novacyt, Anatolia Geneworks. |
| What is the current market cap of Euroinvestment? | Euroinvestment's current market cap is $2M. |
| Is Euroinvestment profitable? | No, Euroinvestment is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.